[Form 4] Addus HomeCare Corp. Insider Trading Activity

Rhea-AI Filing Summary

Addus HomeCare Corp. (ADUS) insider filing: Brian Poff, EVP and Chief Financial Officer, reported sales of company common stock on 08/25/2025. He sold 4,106 shares at a weighted-average price of $116.55 (sales ranged $115.76–$116.73) and 3,633 shares at a weighted-average price of $117.13 (sales ranged $116.78–$117.43). After these transactions he beneficially owned 56,980 shares. The Form 4 is signed by Mr. Poff on 08/26/2025 and discloses that the shares were sold in multiple transactions; the filer offers to provide detailed per-price quantities on request.

Insights

Financial Analyst

TL;DR: Insider sold a modest number of shares in multiple transactions, disclosed timely via Form 4; no derivatives or purchases reported.

The transaction shows routine disposition by a senior executive rather than an acquisition or exercise. The reported sales total 7,739 shares executed on 08/25/2025 at weighted-average prices of $116.55 and $117.13, leaving 56,980 shares beneficially owned. Because the filing discloses weighted-average prices and offers granular breakdowns on request, transparency around execution is adequate. There is no indication in this Form 4 of transaction-related hedging, option exercises, or a Rule 10b5-1 plan notation.

Corporate Governance Expert

TL;DR: The filing reflects standard insider disclosure practices; sales were reported promptly and properly signed.

From a governance perspective, the Form 4 meets reporting requirements: it identifies the reporting person, relationship to the issuer (EVP, CFO), transaction dates, quantities, and weighted-average prices, and includes an explanatory footnote about price ranges. The signature dated 08/26/2025 indicates timely filing. The form does not state whether sales were pursuant to a pre-arranged plan, so no affirmative defense is claimed here.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POFF BRIAN

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		S		4,106	D	$116.55(1)	60,613	D
Common Stock	08/25/2025		S		3,633	D	$117.13(2)	56,980	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.76 to $116.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.78 to $117.43, inclusive.

	/s/ Brian Poff	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Brian Poff sell in the Form 4 for ADUS?

He sold a total of 7,739 shares of Addus HomeCare common stock on 08/25/2025 in multiple transactions.

At what prices were the ADUS shares sold by the insider?

Sales were at weighted-average prices of $116.55 (range $115.76–$116.73) and $117.13 (range $116.78–$117.43).

How many ADUS shares does Brian Poff own after the reported transactions?

Following the reported sales, he beneficially owned 56,980 shares.

When was the Form 4 for the ADUS insider sale filed and signed?

The transactions occurred on 08/25/2025 and the Form 4 is signed by Brian Poff on 08/26/2025.

Does the Form 4 state the sales were under a 10b5-1 plan?

No. The filing does not indicate that the transactions were made pursuant to a Rule 10b5-1 trading plan.